Zhou L - Search Results

1

Evolution of drug regulations and regulatory innovation for anticancer drugs in China.

Liu Y, Zhang N, Xie C, Jiang Y, Qin Y, Zhou L, Fan Y, Ren L, Yin C, Yang H, Xie W, Zhai Q, Li G, Chen H, Chen X. Liu Y, et al. Among authors: zhou l. Acta Pharm Sin B. 2022 Dec;12(12):4365-4377. doi: 10.1016/j.apsb.2022.08.004. Epub 2022 Aug 13. Acta Pharm Sin B. 2022. PMID: 36561995 Free PMC article. Review.

2

Evolution of innovative drug R&D in China.

Li G, Liu Y, Hu H, Yuan S, Zhou L, Chen X. Li G, et al. Among authors: zhou l. Nat Rev Drug Discov. 2022 Aug;21(8):553-554. doi: 10.1038/d41573-022-00058-6. Nat Rev Drug Discov. 2022. PMID: 35365768 No abstract available.

3

The evolving treatment paradigm of lung cancer in China.

Xie W, Liu S, Li G, Xu H, Zhou L. Xie W, et al. Among authors: zhou l. Acta Pharm Sin B. 2022 Mar;12(3):1536-1537. doi: 10.1016/j.apsb.2022.01.010. Epub 2022 Jan 29. Acta Pharm Sin B. 2022. PMID: 35530151 Free PMC article. No abstract available.

4

Analysis of new drug registration and review in China in 2021.

Hu H, Lu X, Xu H, Zhou L. Hu H, et al. Among authors: zhou l. Acta Pharm Sin B. 2022 Apr;12(4):2127-2128. doi: 10.1016/j.apsb.2022.02.018. Epub 2022 Feb 24. Acta Pharm Sin B. 2022. PMID: 35847501 Free PMC article. No abstract available.

5

Gene and cell therapies in China: booming landscape under dual-track regulation.

Yin C, Gao J, Li G, Hu H, Zhou L, Lu S, Chen X. Yin C, et al. Among authors: zhou l. J Hematol Oncol. 2022 Oct 5;15(1):139. doi: 10.1186/s13045-022-01354-9. J Hematol Oncol. 2022. PMID: 36199142 Free PMC article.

6

Drug discovery in China: A snapshot of recent progress.

Hu H, Xie C, Xu H, Zhou L. Hu H, et al. Among authors: zhou l. Acta Pharm Sin B. 2022 Nov;12(11):4266-4269. doi: 10.1016/j.apsb.2022.08.021. Epub 2022 Aug 28. Acta Pharm Sin B. 2022. PMID: 36386469 Free PMC article. No abstract available.

7

Five trends of China's pharmaceutical industry in 2022.

Chen Y, Song J, Cui Y, Zhou L. Chen Y, et al. Among authors: zhou l. Acta Pharm Sin B. 2023 Jun;13(6):2812-2814. doi: 10.1016/j.apsb.2023.04.004. Epub 2023 Apr 12. Acta Pharm Sin B. 2023. PMID: 37425055 Free PMC article. No abstract available.

8

Mitochondria-Targeted Nanoadjuvants Induced Multi-Functional Immune-Microenvironment Remodeling to Sensitize Tumor Radio-Immunotherapy.

Zhou Z, Li C, Li C, Zhou L, Tan S, Hou W, Xie C, Wang L, Shen J, Xiong W. Zhou Z, et al. Among authors: zhou l. Adv Sci (Weinh). 2024 May 5:e2400297. doi: 10.1002/advs.202400297. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 38704675

9

Precise execution of personalized surgical planning using three-dimensional printed guide template in severe and complex adult spinal deformity patients requiring three-column osteotomy: a retrospective, comparative matched-cohort study.

Zhang Y, Yang H, Han C, Zhang Y, Zhou L, Hai Y. Zhang Y, et al. Among authors: zhou l. J Orthop Surg Res. 2024 May 4;19(1):278. doi: 10.1186/s13018-024-04712-0. J Orthop Surg Res. 2024. PMID: 38704574

10

Correction: Triglyceride-glucose index in early pregnancy predicts the risk of gestational diabetes: a prospective cohort study.

Guo Y, Lu J, Bahani M, Ding G, Wang L, Zhang Y, Zhang H, Liu C, Zhou L, Liu X, Li F, Wang X, Ding H. Guo Y, et al. Among authors: zhou l. Lipids Health Dis. 2024 May 4;23(1):132. doi: 10.1186/s12944-024-02110-3. Lipids Health Dis. 2024. PMID: 38704554 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30,962 results

Search Page